| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Jianjun Chen
|
Prior to Jul 01, 2020 |
||||||
| GSE65939 |
Both gain and loss of function of miR-126 promote t(8;21) leukemia progression with different consequences and through different mechanisms
|
39 | Jianjun Chen | Sep 07, 2015 | ||||
| GSE68643 |
PBX3 cooperates with MEISI in causing rapid acute myeloid leukemia and recapitulates the core transcriptome of MLL-rearranged leukemia
|
20 | Jianjun Chen | Mar 03, 2016 | ||||
| GSE76414 |
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO
|
8 | Jianjun Chen | Dec 20, 2016 | ||||
| GSE84944 |
N6-methyladenosine (m6A) sequencing of messenger RNAs in acute myeloid leukemia (AML) cells with and without knockdown of FTO
|
2 | Jianjun Chen | Dec 20, 2016 | ||||
| GSE85008 |
mRNA sequencing in acute myeloid leukemia (AML) cells with and without knockdown of FTO
|
2 | Jianjun Chen | Dec 20, 2016 | ||||
| GSE87187 |
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control
|
13 | Jianjun Chen | Dec 14, 2017 | ||||
| GSE87189 |
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment
|
12 | Jianjun Chen | Dec 14, 2017 | ||||
| GSE87190 |
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-M6A Seq
|
20 | Jianjun Chen | Dec 14, 2017 | ||||
| GSE90639 |
Transcriptome-wide identification of IGF2BP binding RNAs by RIP-seq.
|
6 | Jianjun Chen | Mar 15, 2018 | ||||
| GSE90642 |
Profiling of N6-Adenosine (m6A) Methylation in HepG2 cells
|
8 | Jianjun Chen | Mar 26, 2018 | ||||
| GSE90684 |
IGF2BP proteins Enhance mRNA stability
|
30 | Jianjun Chen | Mar 15, 2018 | ||||
| GSE90686 |
Recognition of RNA N6-methyadenosine by IGF2BP proteins Enhances mRNA Stability
|
44 | Jianjun Chen | Mar 15, 2018 | ||||
| GSE94840 |
ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia
|
4 | Jianjun Chen | Jun 09, 2017 | ||||
| GSE97408 |
N6-methyladenosine (m6A) sequencing of messenger RNAs in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 [m6A-seq]
|
8 | Jianjun Chen | Dec 29, 2017 | ||||
| GSE97443 |
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14
|
8 | Jianjun Chen | Dec 29, 2017 | ||||
| GSE103143 |
The mechanism of HHT in treating acute myeloid leukemia on RNA level.
|
6 | Jianjun Chen | Dec 19, 2019 | ||||
| GSE103144 |
Genome wide browser of 5hmc abundance in MA9.3ITD cell with PBS or HHT treatment.
|
2 | Jianjun Chen | Dec 19, 2019 | ||||
| GSE103494 |
RNA seq with AML cells (NB4) upon FTO knockdown
|
4 | Jianjun Chen | Apr 29, 2019 | ||||
| GSE103495 |
RNA seq with AML (NB4) cells upon FTO inhibition
|
9 | Jianjun Chen | Apr 29, 2019 | ||||
| GSE103496 |
Sequencing of mRNA with N6-methyladenosine (m6A) modification in AML cells upon DMSO or FTO inhibitor treatment
|
3 | Jianjun Chen | Apr 29, 2019 |
